NOX4 and diabetes mellitus: Together with our other data, these findings represent important mechanistic insight into the specific role of ECFC NOX4 in determining angiogenic function in both experimental and clinical diabetes, whilst providing exciting opportunity for targeted intervention towards improved management of ischaemic CVD in diabetic patients.